Volume 8, Number 5—May 2002
First Shiga Toxin-Producing Escherichia coli Isolate from a Patient with Hemolytic Uremic Syndrome, Brazil
To the Editor: Infection by Shiga toxin (Stx)-producing Escherichia coli (STEC), particularly strains of serotype O157:H7, can cause sporadic cases and outbreaks of diarrhea, hemorrhagic colitis (HC), and hemolytic uremic syndrome (HUS) (1). Some other serotypes (e.g., O26:H11, O111:H8, O111:NM, and O113:H21) share a similar pathogenic potential. STEC are distributed worldwide, but most of the HC and HUS cases were reported from industrialized nations of the Northern and Southern hemisphere (2). In South America, HUS is a major cause of acute renal failure in infants in Argentina (3) and Chile (4). However, in Brazil human STEC infections have been restricted to sporadic cases of nonbloody diarrhea (5,6). Although a high frequency of STEC strains was recently found in foods and animal reservoirs (7,8), only some of the serotypes identified in animals (8) were recognized as causes of human illness (e.g., O157:H7, O22:H16, O82:H8, and NT:H21). Moreover, there is currently no nationwide surveillance system for HUS in Brazil, and STEC-associated HUS has not been previously reported in our country.
We describe the case of an 8-month-old boy from a northeastern state in Brazil, who was admitted to the emergency room of Hospital São Paulo, São Paulo, on March 17, 2001; the boy had anemia, oliguria, and edema of lower extremities. He had an acute diarrheal prodromal illness 3 weeks before hospital admission. On the same day as admission, respiratory failure developed, and the child was transferred to the pediatric intensive-care unit of the hospital. The boy had hemolytic anemia (hemoglobin level 11.9 g/dL at admission, and 9.1 g/dL several days later), renal failure (blood urea nitrogen 43.8 mg/dL and serum creatinine 1.5 mg/dL), and thrombocytopenia (platelet count of 70,000/mm3), leading to a diagnosis of HUS. The patient received treatment with fresh frozen plasma and needed renal support (peritoneal dialysis) for 7 days. Once renal function was reestablished, the patient’s outcome was good.
Feces were collected as soon as HUS was suspected and plated onto MacConkey Sorbitol Ágar (Difco, Becton Dickinson Microbiology Systems, Sparks, MD). Only sorbitol-positive colonies grew and were biochemically identified as E. coli by standard procedures. The E. coli isolates expressed Stx1, as identified by cytotoxicity and neutralization assays on Vero cells (5). Presence of stx1 and intimin (eae) gene sequences was confirmed by polymerase chain reaction (9,10). The E. coli strain belonged to serotype O26:H11 and produced enterohemorragic E. coli hemolysin (enterohemolysin).
This report is the first on the isolation of an STEC strain in a HUS patient in Brazil. The serotype O26:H11 has been described as agent of HC and HUS in other countries and was the second most frequent serotype found in STEC strains isolated from diarrheal cases in our settings (6). Moreover, expression of Stx1 and enterohemolysin and the presence of eae are virulent characteristics usually found in the human STEC strains isolated so far in Brazil. These findings show the importance of looking for non-O157 STEC strains besides O157:H7 in patients with HC and HUS in Brazil. Surveillance for HUS, either nationally or in sentinel population-based studies, should be performed in Brazil, and studies on the occurrence of HUS and its association with STEC infections are under investigation in our laboratory.
We thank Dr. A.T. Tânia Gomes for encouragement on this subject.
- Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98.
- Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11:142–201.
- Rivas M, Balbi L, Miliwebsky E, Garcia B, Tous M, Leardini N, Síindrom Urémico Hemolítico en niños de Mendoza, Argentina: su asociación con la infección por Escherichia coli productor de toxina Shiga. Medicina (B Aires). 1998;58:1–7.
- Cordovez A, Padro V, Maggi L, Cordero J, Martinez J, Misraji A, Enterohemorragic Escherichia coli associated with hemolytic uremic syndrome in Chilean children. J Clin Microbiol. 1992;30:2153–7.
- Giraldi R, Guth BEC, Trabulsi LR. Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil. J Clin Microbiol. 1990;28:1460–2.
- Irino K, Gomes TAT, Vaz TI, Kano E, Kato MAMF, Dias AMG, Prevalence of Shiga toxin and intimin gene sequences among Escherichia coli of serogroups O26, O55, O111, O119 and O157 isolated in São Paulo, Brazil. In: Abstracts of the 4th International Symposium and Workshop on Shiga toxin (Verocytotoxin)- producing Escherichia coli infections. Kyoto, Japan, 2000; p.107.
- Cerqueira AMF, Tibana A, Guth BEC. High occurrence of Shiga-like-toxin-producing strains among diarrheagenic Escherichia coli isolated from raw beef products in Rio de Janeiro City, Brazil. J Food Prot. 1997;60:1–5.
- Cerqueira AMF, Guth BEC, Joaquim RM, Andrade JRC. High occurrence of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle at Rio de Janeiro State, Brazil. Vet Microbiol. 1999;70:111–21.
- Pollard DR, Johnson WM, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol. 1990;28:540–5.
- Gannon V, Rashed M, King R, Golsteyn TE. Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction. J Clin Microbiol. 1993;31:1268–74.
Suggested citation: Guth BEC, Lopes de Souza R, Vaz TMI, and Irino K. First Shiga Toxin-Producing Escherichia coli Isolate from a Patient with Hemolytic Uremic Syndrome, Brazil. Emerg Infect Dis. [serial on the Internet]. 2002 May [date cited]. Available from http://wwwnc.cdc.gov/eid/article/8/5/01-0419
- Page created: July 15, 2010
- Page last updated: July 15, 2010
- Page last reviewed: July 15, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)